ViroPharma Incorporated today announced that it has initiated an open-label, single-dose Phase 2 study to evaluate doses of Cinryze (C1 esterase inhibitor [human)] for treatment of acute angioedema attacks in children less than 12 years of age with hereditary angioedema.
Filed under: Main Content | No Comments »
JACKSONVILLE, Fla. — Allergy season has already started and is off to a unfortunate woozy start.
Filed under: Main Content | No Comments »
Need a place to store your gum when you’re done chewing it? There’s a gadget for that. Ever hoped to grate vegetables while you play your ukulele? There’s a gadget for that.�
Filed under: Main Content | No Comments »
ViroPharma Incorporated today announced that the European Medicines Agency (EMA) has accepted the filing of its Marketing Authorization Application for Cinryze for acute treatment and prophylaxis against hereditary angioedema, which was submitted through the centralized procedure in March 2010. ViroPharma is seeking European approval for both prevention and treatment of acute attacks of …
Filed under: Main Content | No Comments »
Who knew there is a ukulele that grates vegetables? The device that can make vegetables sing was one of the offbeat inventions at the Fringe Festival in Dunedin, New Zealand.
Filed under: Main Content | No Comments »
